Literature DB >> 25559515

Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion.

Mrinali Patel Gupta, Peter Coombs, Susan E Prockop, Aisha A Hasan, Ekatarina Doubrovina, Richard J O'Reilly, Stuart H Cohen, Susanna S Park, Szilárd Kiss.   

Abstract

Cytomegalovirus (CMV) retinitis is a potentially blinding infection that affects immunocompromised patients who are unable to generate a T-cell response against the organism. Infusion of CMV-specific leukocytes has been shown to be effective in patients with systemic CMV infection, especially those resistant to standard therapies. The authors report a case of a patient with CMV viremia with progressive retinitis in whom infusion of third-party donor-derived CMV pp65-specific T cells alone prompted resolution of CMV retinitis. This case suggests a potential role for CMV-specific leukocyte infusion in the treatment of CMV retinitis, especially in cases resistant or refractory to antiviral therapies. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25559515      PMCID: PMC4373317          DOI: 10.3928/23258160-20150101-14

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  8 in total

Review 1.  Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents.

Authors:  Aswani D Vadlapudi; Ramya K Vadlapatla; Ashim K Mitra
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2012-04

2.  Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

Authors:  Tobias Feuchtinger; Kathrin Opherk; Wolfgang A Bethge; Max S Topp; Friedhelm R Schuster; Eva M Weissinger; Mohamad Mohty; Reuven Or; Michael Maschan; Michael Schumm; Klaus Hamprecht; Rupert Handgretinger; Peter Lang; Hermann Einsele
Journal:  Blood       Date:  2010-07-12       Impact factor: 22.113

3.  Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.

Authors:  B Bodaghi; M E Slobbe-van Drunen; A Topilko; E Perret; R C Vossen; M C van Dam-Mieras; D Zipeto; J L Virelizier; P LeHoang; C A Bruggeman; S Michelson
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-10       Impact factor: 4.799

4.  A case of immune recovery vitritis induced by donor leukocyte infusion for the treatment of cytomegalovirus retinitis.

Authors:  Manabu Kawakami; Jun Nakata; Nobuyuki Ohguro; Satoshi Yoshihara; Takayuki Inoue; Toyoshi Tatekawa; Kazuhiro Ikegame; Yoshihiro Oka; Ichiro Kawase; Hiroyasu Ogawa
Journal:  Eur J Haematol       Date:  2005-10       Impact factor: 2.997

5.  Role of retinal vascular endothelial cells in development of CMV retinitis.

Authors:  N A Rao; J Zhang; S Ishimoto
Journal:  Trans Am Ophthalmol Soc       Date:  1998

6.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

Authors:  Hermann Einsele; Eddy Roosnek; Nathalie Rufer; Christian Sinzger; Susanne Riegler; Jürgen Löffler; Ulrich Grigoleit; Arnaud Moris; Hans-Georg Rammensee; Lothar Kanz; Annette Kleihauer; Friederike Frank; Gerhard Jahn; Holger Hebart
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

7.  Cytomegalovirus and the eye.

Authors:  A Carmichael
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

8.  Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy.

Authors:  Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

  8 in total
  6 in total

1.  Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis.

Authors:  Shiney Seo; Corey Smith; Christopher Fraser; Rajan Patheja; Shaheen P Shah; Sweera Rehan; Pauline Crooks; Michelle A Neller; Rajiv Khanna
Journal:  Blood Adv       Date:  2019-06-11

2.  Cytomegalovirus retinitis in the post-cART era.

Authors:  Alexander D Port; Rolake O Alabi; Lisa Koenig; Mrinali P Gupta
Journal:  Curr Ophthalmol Rep       Date:  2018-05-02

3.  Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes.

Authors:  Mrinali P Gupta; Lisa R Koenig; Ekaterina Doubrovina; Aisha Hasan; Parastoo B Dahi; Richard J O'Reilly; Guenther Koehne; Anton Orlin; Robison V Paul Chan; Donald J D'Amico; Susanna S Park; Bryn M Burkholder; Szilárd Kiss
Journal:  Ophthalmol Retina       Date:  2021-04-20

4.  High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation.

Authors:  Yuehong Zhang; Xiangcai Ruan; Weizhong Yang; Ling Li; Zhuanhua Xian; Qiting Feng; Wenjian Mo
Journal:  BMC Ophthalmol       Date:  2017-11-29       Impact factor: 2.209

5.  SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULA-INVOLVING CYTOMEGALOVIRUS RETINITIS.

Authors:  Mrinali P Gupta; Sarju Patel; Anton Orlin; Elizabeth Marlow; Ru-Ik Chee; Jennifer Nadelmann; R V Paul Chan; Donald J DʼAmico; Szilard Kiss
Journal:  Retina       Date:  2018-05       Impact factor: 4.256

Review 6.  Cytomegalovirus Retinitis in HIV and Non-HIV Individuals.

Authors:  Monique Munro; Tejabhiram Yadavalli; Cheryl Fonteh; Safa Arfeen; Ann-Marie Lobo-Chan
Journal:  Microorganisms       Date:  2019-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.